[6] Lanoot B., Vancanneyt M., Cleenwerck I., Wang L., Li W., Liu Z., Swings J.,
The Search for Synonyms Among Streptomycetes by Using SDS-PAGE of Whole-Cell Proteins. Emendation of the Species Streptomyces aurantiacus, Streptomyces Cacaoi Subsp. Cacao, Streptomyces Caeruleus And Streptomyces Violaceus,
Int. J. Syst. Evol. Microbial.,
52: 823-829 (2002).
[8] Flavin M.T., Rizzo J.D., Khilevich A., Kucherenko A., Sheinkman A.K., Vilaychack V., Lin L., Chen W., Greenwood E.M., Pengsuparp T., Pezzuto J.M.,
Synthesis, Chromatographic Resolution, and Anti-Human Immunodeficiency Virus Activity of (±)-Calanolide A and Its Enantiomers,
J. Med. Chem., 39: 1303-1313 (1996).
[9] Seitz W., Geneste H., Backfisch G., Delzer J., Graef C., Hornberger W., Kling A., Subkowski T., Zimmermann N.,
Design and Synthesis of Novel Potent and Selective Integrin α v β 3 Antagonists—Novel Synthetic Routes to Isoquinolinone, Benzoxazinone, and Quinazolinone Acetates,
Bioorg. Med. Chem. Lett.,
18: 527-531 (2008).
[11] Wang H., Sun B., Yang J., Wang J., Mao P., Yang L., Mai W.,
The synthesis of 3, 4-disubstituted Dihydroquinolin-2 (1H)-one under Metal-Free Conditions in Aqueous Solution,
J. Chem. Res.,
38: 542-545 (2014).
[13] Nishi T., Tabusa F., Tanaka T., Shimizu T., Kanbe T., Kimura Y., Nakagava K.,
Studies on 2-Oxoquinoline Derivatives as Blood Platelet Aggregation Inhibitors. II. 6-[3-(1-cyclohexyl- 5-tetrazolyl) propoxy]-1, 2-dihydro-2-oxoquinoline and Related Compounds,
Chem. Pharm. Bull.,
31: 1151-1157 (1983).
[15] Joseph B., Darro F., Béhard A., Lesur B., Collignon F., Decaestecker C., Frydman A., Guillaumet G., Kiss R.,
3-Aryl-2-Quinolone Derivatives: Synthesis and Characterization of in Vitro and in Vivo Antitumor Effects with Emphasis on a New Therapeutical Target Connected with Cell Migration,
J. Med. Chem.,
45: 2543-2555 (2002).
[16] Nishi T., Tabusa F., Tanaka T., Shimizu T., Nakagawa K.,
Studies on 2-Oxoquinoline Derivatives as Blood Platelet Aggregation Inhibitors. IV. Synthesis and Biological Activity of the Metabolites of 6-[4-(1-cyclohexyl-1H-5-tetrazolyl) butoxy]-2-oxo-1, 2, 3, 4-tetrahydroquinoline (OPC-13013),
Chem. Pharm. Bull.,
33: 1140-1147 (1985).
[18] Suzuki M., Ohuchi Y., Asanuma H., Kaneko T., Yokomori S., Ito C., Isobe Y., Muramatsu M.,
Synthesis and Evaluation of Novel 2-oxo-1, 2-dihydro-3-quinolinecarboxamide Derivatives as Serotonin 5-HT4 Receptor Agonists,
Chem. Pharm. Bull.,
48: 2003-2008 (2000).
[24] Horn J., Li H.Y., Marsden S.P., Nelson A., Shearer R.J., Campbell A.J., House D., Weingarten G.G.,
Convergent Synthesis of Dihydroquinolones from o-aminoarylboronates,
Tetrahedron,
65: 9002-9007 (2009).